NAFLD/MAFLD: New Evidence
- PMID: 37108404
- PMCID: PMC10138393
- DOI: 10.3390/ijms24087241
NAFLD/MAFLD: New Evidence
Abstract
The aim of the second edition of our Special Issue, entitled "Nonalcoholic Fatty Liver Disease/Metabolic Associated Fatty Liver Disease: New Insights 2 [...].
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Metabolic Dysfunction-associated Fatty Liver Disease and Mortality Among Chinese Adults: a Prospective Cohort Study.J Clin Endocrinol Metab. 2022 Jan 18;107(2):e745-e755. doi: 10.1210/clinem/dgab644. J Clin Endocrinol Metab. 2022. PMID: 34467980
-
Risk of cardiovascular disease in patients with fatty liver disease as defined from the metabolic dysfunction associated fatty liver disease or nonalcoholic fatty liver disease point of view: a retrospective nationwide claims database study in Japan.J Gastroenterol. 2021 Nov;56(11):1022-1032. doi: 10.1007/s00535-021-01828-6. Epub 2021 Oct 3. J Gastroenterol. 2021. PMID: 34601620 Free PMC article.
-
Nonalcoholic fatty liver disease versus metabolic-associated fatty liver disease: Prevalence, outcomes and implications of a change in name.Clin Mol Hepatol. 2022 Oct;28(4):790-801. doi: 10.3350/cmh.2022.0070. Epub 2022 May 11. Clin Mol Hepatol. 2022. PMID: 35545437 Free PMC article. Review.
-
Comparative Associations of Nonalcoholic Fatty Liver Disease and Metabolic Dysfunction-Associated Fatty Liver Disease With Coronary Artery Calcification: A Cross-Sectional and Longitudinal Cohort Study.Arterioscler Thromb Vasc Biol. 2023 Mar;43(3):482-491. doi: 10.1161/ATVBAHA.122.318661. Epub 2023 Feb 2. Arterioscler Thromb Vasc Biol. 2023. PMID: 36727522
-
MAFLD: How is it different from NAFLD?Clin Mol Hepatol. 2023 Feb;29(Suppl):S17-S31. doi: 10.3350/cmh.2022.0367. Epub 2022 Nov 29. Clin Mol Hepatol. 2023. PMID: 36443926 Free PMC article. Review.
Cited by
-
NAFLD in the 21st Century: Current Knowledge Regarding Its Pathogenesis, Diagnosis and Therapeutics.Biomedicines. 2024 Apr 9;12(4):826. doi: 10.3390/biomedicines12040826. Biomedicines. 2024. PMID: 38672181 Free PMC article. Review.
References
-
- Mantovani A., Taverna A., Cappelli D., Beatrice G., Csermely A., Sani E., Byrne C.D., Targher G. Long-Term Adverse Effect of Liver Stiffness on Glycaemic Control in Type 2 Diabetic Patients with Nonalcoholic Fatty Liver Disease: A Pilot Study. Int. J. Mol. Sci. 2022;23:12481. doi: 10.3390/ijms232012481. - DOI - PMC - PubMed
-
- Vigano M., Pugliese N., Cerini F., Turati F., Cimino V., Ridolfo S., Rocchetto S., Foglio F., Terrin M., La Vecchia C., et al. Accuracy of FIB-4 to Detect Elevated Liver Stiffness Measurements in Patients with Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study in Referral Centers. Int. J. Mol. Sci. 2022;23:12489. doi: 10.3390/ijms232012489. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical